{"id":17190,"date":"2026-04-04T18:00:08","date_gmt":"2026-04-04T21:00:08","guid":{"rendered":"https:\/\/rtmedical.com.br\/aaa-eclipse-algorithm-explained\/"},"modified":"2026-04-04T19:57:56","modified_gmt":"2026-04-04T22:57:56","slug":"aaa-eclipse-algorithm-explained","status":"publish","type":"post","link":"https:\/\/rtmedical.com.br\/en\/aaa-eclipse-algorithm-explained\/","title":{"rendered":"AAA Explained: Beamlets, Anisotropic Kernels, and Heterogeneity Correction in Eclipse"},"content":{"rendered":"

AAA<\/span> stayed at the center of clinical photon planning long enough to become a default assumption in many departments. That is exactly why it is often described too loosely. People call it \u201cbetter than pencil beam\u201d and \u201clighter than explicit transport,\u201d which is true in a broad market sense but not very useful if the goal is to understand how the algorithm actually behaves in a plan.<\/p>\n

Inside Eclipse<\/span>, the Anisotropic Analytical Algorithm<\/span> is more interesting as engineering than as branding. It was designed to pull much more physics into routine photon dose calculation without pushing the workflow into the computational cost of explicit transport solvers. That balance is what made it clinically important, and it is also what explains its limitations.<\/p>\n

To read AAA<\/span> properly, it helps to break the problem into three layers:<\/p>\n

    \n
  1. how the beam is modeled before entering the patient;<\/li>\n
  2. how the treatment field is decomposed into beamlets<\/span>;<\/li>\n
  3. how longitudinal and lateral energy deposition are handled in heterogeneous tissue.<\/li>\n<\/ol>\n

    The point is not simply to repeat that AAA<\/span> \u201caccounts for heterogeneity.\u201d The useful question is what it does, where it remains very strong, and why the Varian documentation itself recommends caution in specific scenarios.<\/p>\n

    \n

    In this Article<\/h2>\n